Therapy and Prophylaxis of Bleeding Symptoms in a Patient with Acquired Factor X-Deficiency due to Systemic AMyloidosis (AL-AMyloidosis)

Author(s):  
R. Klamroth ◽  
Ch. Heinrichs
2011 ◽  
Vol 4 (2) ◽  
pp. 101-103
Author(s):  
R. Raina ◽  
V. Nadig ◽  
D. Patel ◽  
A. Jegalian ◽  
B. Silver ◽  
...  

1984 ◽  
Vol 34 (3) ◽  
pp. 639-647
Author(s):  
Hiroyuki Shibuya ◽  
Norio Azumi ◽  
Fumihiko Abe ◽  
Masataka Deno ◽  
Shohki Sakurama

Blood ◽  
2001 ◽  
Vol 97 (6) ◽  
pp. 1885-1887 ◽  
Author(s):  
Elie B. Choufani ◽  
Vaishali Sanchorawala ◽  
Timothy Ernst ◽  
Karen Quillen ◽  
Martha Skinner ◽  
...  

Acquired deficiency of factor X occurs in patients with systemic amyloid light-chain (AL) amyloidosis, presumably due to adsorption of factor X to amyloid fibrils. Of 368 consecutive patients with systemic AL amyloidosis evaluated at Boston Medical Center, 32 patients (8.7%) had factor X levels below 50% of normal. Eighteen of these patients (56%) had bleeding complications, which were more frequent and severe in the 12 patients below 25% of normal; 2 episodes were fatal. Ten factor X–deficient patients received high-dose melphalan chemotherapy followed by autologous stem cell transplantation. Of 7 patients alive 1 year after treatment, 4 had a complete hematologic response, and all 4 experienced improvement in their factor X levels. One of 2 additional patients with partial hematologic responses had improvement in factor X. Thus, aggressive treatment of the underlying plasma cell dyscrasia in AL amyloidosis can lead to the amelioration of amyloid-related factor X deficiency.


1979 ◽  
Author(s):  
F Peuscher ◽  
W van Aken ◽  
A Swaak ◽  
L Sie ◽  
L Statius van Eps

An isolated deficiency of factor X is known to occur in a hereditary form, the Stuart-Prower disease, and in an acquired form in some patients with para-proteinaemia and sporadically in systemic amyloidosis. Transient deficiency of factor X in the presence of normal levels of factors II, VII and V appears to be rare. In the literature, only three cases have been described. We have studied a patient with a severe haemorrhagic diathesis and concomitant mycoplasma pneumonial infection. The bleeding tendency proved to be due to isolated factor X deficiency. No circulating inhibitors of factor X were present. Systemic amyloidosis could not be demonstrated. Factor X-related antigen could not be detected (this test was kindly performed by Dr.Daryl S.Fair, Scripps Clinic and Research Foundation, La Jolla, U.S.A.). Treatment with vitamin K, prothrombin complex concentrate, fresh plasma and whole blood proved not to influence factor X activity in the patient’s plasma. However, 20 days after admission⋅to hospital both factor X activity and antigen spontaneously returned to normal. These results suggest that the synthesis of factor X was transiently defective. Since other conditions known to affect factor X activity could not be demonstrated, it is postulated that the acquired factor X deficiency in this patient was related to the infection with mycoplasma pneumoniae.


2012 ◽  
Vol 24 (10) ◽  
pp. 479-482
Author(s):  
Emmanuelle Weber ◽  
Serge Charmion ◽  
Catherine Bozon ◽  
Pascal Cathébras

2019 ◽  
Vol 12 (1) ◽  
pp. 10-14 ◽  
Author(s):  
Gina Patel ◽  
Parameswaran Hari ◽  
Aniko Szabo ◽  
Lisa Rein ◽  
Lisa Baumann Kreuziger ◽  
...  

2014 ◽  
Vol 53 (16) ◽  
pp. 1841-1845 ◽  
Author(s):  
Masanori Furuhata ◽  
Noriko Doki ◽  
Tsunekazu Hishima ◽  
Tomomi Okamoto ◽  
Takatoshi Koyama ◽  
...  

1977 ◽  
Vol 297 (2) ◽  
pp. 81-85 ◽  
Author(s):  
Bruce Furie ◽  
Edith Greene ◽  
Barbara C. Furie

Sign in / Sign up

Export Citation Format

Share Document